-
How eTMF Can Improve Global Clinical Trials
How eTMF Systems Are Shaping Global Clinical Trials Managing documentation across global clinical trials is complex, but eTMF systems are transforming how sponsors, CROs, and sites stay compliant and efficient. By replacing fragmented, paper-based processes with centralized digital platforms, eTMFs improve visibility, collaboration, and regulatory readiness across regions. This blog explores how eTMFs support smoother…
-
How to Make eConsent Accessible Across Diverse Populations
Designing Accessible eConsent for Inclusive Clinical Trials Making eConsent accessible across diverse clinical trial populations means designing consent flows that participants can truly understand and use, regardless of language, literacy level, disability, or device access. Effective programs pair plain-language writing and chunked, participant-centered layouts with multilingual translation and localization that stay consistent through version control.…
-
When to Use Wearables in a Clinical Trial and How to Get Started
Wearables have moved well beyond pilot projects and proof-of-concept studies. Many sponsors are already exploring how continuous activity, physiological, and behavioral data can strengthen their clinical programs. The question now is not whether wearables can collect data. It is where that data truly adds value and how to incorporate it without adding operational complexity. Not…
-
How AI Activates the Full Potential of Wearables in Clinical Research
Wearables are no longer experimental. Smartwatches, activity trackers, connected scales, and mobile health apps are already part of daily life for millions of people. In clinical research, they offer something sponsors have wanted for decades: continuous, real-world insight into how patients are actually functioning outside the clinic. But there is a gap between collecting wearable…
-
What Is ePRO?
Electronic patient-reported outcomes (ePROs) are increasingly important in modern clinical trials. ePRO can record how patients feel, function, and respond to treatment without needing site visits or paper reports. As studies focus more on patient outcomes and shift away from traditional models, ePRO offers a reliable way to collect real-time data from participants. This tool…
-
What Is eCOA?
Electronic clinical outcome assessment (eCOA) is a way to collect clinical trial data using digital tools. As clinical trials become more flexible and focused on patients, eCOA has become necessary for improving data quality and making studies run more smoothly. For sponsors and contract research organizations (CROs), eCOA delivers a more dependable method for capturing…
-
AI Implementation Challenges with Legacy EDC Systems: Is Your EDC Limiting the Impact of AI on Your Data?
AI is increasingly being adopted in clinical trials to help teams keep pace with growing data demands. The goal is clear: reduce manual effort, surface insights sooner, and support better decisions. But for many sponsors, those benefits are harder to realize in day-to-day trial work. Often, the challenge is not the AI itself. It is…
-
AI in Clinical Trials: Practical Use Cases for Data Management
AI in clinical trials is increasingly being judged by how well it supports real data management work. Instead of focusing on abstract promises or futuristic scenarios, sponsors are asking a more practical question: How can AI actually help my data management team do better work today? When applied thoughtfully, AI in clinical trials can make…
-
Clinical Data Modernization: A 2026 Starter Guide
Clinical data modernization is one of those phrases that shows up everywhere and means something different to almost everyone. In some contexts, it refers to cloud infrastructure. In others, it points to advanced analytics or artificial intelligence. For many clinical teams, it simply signals that current ways of working are starting to strain under growing…
-
What Clinical Teams Should Prepare for in 2026: AI, Automation, and Unified Platforms
As clinical trial operations approach 2026, the conversation around technology is shifting. Tools that were once framed as innovative or experimental are becoming standard. Artificial intelligence, automation, and unified platforms are increasingly seen as baseline needs for running modern trials. This change is being driven by practical pressures rather than novelty. Studies are more distributed,…
